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Technical Report
Abstract
Purpose: To evaluate the influence of collimator rotation in IMRT planning with respect to the target coverage and dose to crit-
ical structures. In addition, the delivery efficiency of desired fluence with collimator rotation is assessed.Methods: The computed
tomography (CT) datasets of 5 patients with parotid cancer were employed for this study. Dynamic IMRT plans were generated
with a dose prescription of 60 Gy in 30 fractions. IMRT plans were generated with five unilateral fields using 6MV X-rays. Four
different plans were generated for each patient by keeping the collimator angle at 0, 30, 60, and 90 degree. All plans were ana-
lyzed using dose volume histogram. Conformity index (CI) and heterogeneity index (HI) were calculated. The total monitor units
(MU) required to deliver one fraction were noted and compared. To verify the delivery efficiency; the measured fluence on IBA
I’mRT MatriXX ionization chamber array detector was compared with the TPS dose plan with 2D gamma evaluation. Results:
There is not much difference in the PTV Dmax and Dmean with respect to the different collimator angles. The PTV coverage is
best at collimator angle of 0 degree. A slight reduction in CI was observed with plans at other collimator angles as compared to 0
degree. The HI values were almost similar for plans with collimator angle 0, 30, and 60 degree. The plan with 90 degree collimator
showed a slightly higher heterogeneity for the PTV. A slight reduction in the average Dmax to spinal cord was observed for the
plan with collimator angle 30 degree as compared to other angles whereas maximum value of Dmax to spinal cord was at colli-
mator angle 60 degree. No clinically relevant difference was observed among the plans with respect to brainstem and mandible
Dmax. An increase in average of oral cavity Dmax and Dmean was observed for collimator angle 60 and 90 degree as compared to
collimator angle 0 and 30 degree. Not much difference was observed with respect to Dmax and Dmean for contralateral parotid
and cochlea with plans at different collimator angles. A decrease in MU required to deliver a fraction was observed for the plan
with collimator angle 30 degree as compared to other angles. The plan with 90 degree collimator required maximum MU. The 2D
γ index evaluation of planned and delivered fluence showed almost similar results for plans with different collimator angles.
Conclusion: An individual case-specific collimator rotation may aid in achieving the desired dose distribution and relative sparing
of critical structures in IMRT.
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Introduction
The advent of linear accelerator and multi-leaf collimator
(MLC) has allowed achieving a conformal radiation treat-
ment. With the movement of MLC, the intensity of beam is
modulated. Intensity modulated radiation therapy (IMRT)1-5
can be delivered in two ways i.e., dynamic and static. IMRT
carries the potential to acquire the desired shape and gradient
of dose distribution to achieve target conformity with fewer
doses to normal structures. In the IMRT planning process, the
number of fields, beam orientation, beam energy, couch
rotation and other parameters are changed one by one for
optimization to achieve the best dose distribution. The col-
limator rotation gives additional degree of freedom, however
the planning and treatment delivery becomes complex. Yang
et al.6 investigate the effects of collimator and couch angle
change on the dose distribution for breast cancer treatment
using intensity-modulated tangential photon beams and re-
sults showed that 4° change in the collimator angle or the
couch angle did not affect the dose distribution significantly.
Isa et al.7 studied the dose-volume variations of planning
target volume (PTV) and organs-at-risk (OARs) in prostate
volumetric modulated arc therapy (VMAT) at different col-
limator angles (0o, 15o, 30o, 45o, 60o, 75o) using a Harold het-
erogeneous pelvis phantom. Results showed that PTV dose
coverage for each plan was comparatively independent of the
collimator angle. A higher CI (0.53) and lower HI (0.064)
were found at 45o collimator angle and rectum sparing was
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good at 75o and 90o collimator angle. In continuation of the
above work we designed a study to evaluate the influence of
collimator rotation in IMRT planning with respect to the
target coverage and dose to critical structures for parotid
cancer. In addition, the delivery efficiency of desired fluence
with collimator rotation is assessed.
Methods and Materials
The computed tomography (CT) datasets of 5 patients with
parotid cancer were employed for this study. Post-operative
radiotherapy was planned for these patients. The patients
were immobilized with a thermoplastic cast with head turned
towards contralateral side at 90 degree. The CT scan was
performed with 3 mm slice thickness. The images were
transferred to the Eclipse (Varian medical system, Palo Alto,
CA, Helios version 6.5) treatment planning system (TPS)
through DICOM. The delineation of clinical target volume
(CTV), planning target volume (PTV), and organs at risk
(OARs) viz., spinal cord, brainstem, contralateral parotid and
cochlea, oral cavity, and mandible was performed. Dynamic
IMRT plans were generated for Varian CL2300C/D linear
accelerator. A dose of 60 Gy in 30 fractions was prescribed.
The following dose volume constraints were specified: atleast
95% of PTV to receive 95% of the prescribed dose, brainstem
maximum dose (Dmax) ≤ 54Gy, spinal cord Dmax ≤ 45 Gy,
contralateral cochlea mean dose (Dmean) ≤ 45Gy, contrala-
teral parotid gland Dmean ≤ 26Gy, mandible Dmax ≤ 70Gy,
and oral cavity Dmean ≤ 45Gy.
IMRT plans were generated with five unilateral fields using
6MV X-rays.8 For dose calculation pencil beam dose calcula-
tion algorithm at 2.5mm grid resolution was used. During
optimization smoothing parameters were kept as X = 40, and
Y = 30. Four different plans were generated for each patient
by changing the collimator angle from 0 to 90 degree in in-
crement of 30 degree. Hence, the plans corresponded to the
collimator angle of 0, 30, 60, and 90 degree. The process of
optimization in the Eclipse TPS is random. Thus, to maintain
the symmetry in generating plans, all plans were optimized
and prescribed in a similar manner to get a valid comparison.
It was not possible to achieve similar optimization result even
with same plan for same patient, to minimize this variation; a
base plan was generated in which collimator angle and all
other optimization parameters (i.e. dose constraints, priority
settings etc.) were fully optimized. Then this base plan was
saved as template plan. For generating plans for other colli-
mator angles, fluence pattern was deleted from the template
(or base) plan and only collimator angle was changed, by
keeping all other parameters constant. IMRT optimization
was continued until no further improvements were noticed
in optimization graph. Similarly, this template plan was ap-
plied for other collimator angles also. The beam’s eye view
(BEV) for a representative patient with respect to the colli-
mator angle 0, 30, 60, and 90 degree in shown in Figure
1(a-d).
FIG. 1(a-d): The beam’s eye view in a representative patient for collimator angle at 0 degree (a), 30 degree (b), 60 degree (c), and 90 degree (d).
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Plan evaluation
All plans were analyzed using dose volume histogram (DVH).
The Dmax and Dmean to brainstem, contralateral parotid,
contralateral cochlea, and oral cavity were noted. The Dmax
to spinal cord and mandible was noted. The target was eval-
uated in terms of maximum, minimum, and mean dose.
Conformity index (CI) and heterogeneity index (HI) were
calculated to analyze the PTV dose coverage and homogene-
ity respectively.9-11
Conformity index (CI)
CI is defined as the ratio of TVRI to TV.
CI = TVRI/TV
TVRI = target volume covered by the reference isodose
TV = target volume
This index ranges from 0 to 1. The volume of adjacent healthy
tissues is not taken into account in this index.
Heterogeneity index (HI):
HI is defined as the ratio of D5% to D95% for the PTV.
HI= D5%/D95%
D5% = dose delivered to 5% of PTV volume
D95% =dose delivered to 95% of PTV volume
It is evident that if the value of heterogeneity index is closer
to 1, the better will be the dose homogeneity for the PTV.
Plan deliverability
The total monitor units (MU) required to deliver one fraction
were noted and compared among the different plans.
Measurement of planned and delivered fluence
The planned fluence was transferred to the previously
scanned I’mRT MatriXX ionization chamber array (IBA Do-
simetry, Scanditronix Wellhofer, Germany). The 4.7 cm slabs
of virtual water phantom were placed above IBA I’mRT Ma-
triXX ionization chamber array and 15 cm below as
backscatter for measurement.
To verify the delivery efficiency, planned fluence was deliv-
ered to the IBA I’mRT MatriXX ionization chamber array
detector. The measured fluence was compared with the TPS
dose plan with OmniPro-I´mRT software (IBA Dosimetry,
Scanditronix Wellhofer, Germany) using 2D Gamma index
(γ) as proposed by Low et al.12 With regard to the reference
gamma value for planned and delivered fluence evaluation, a
criterion was set to 3% dose difference and 3 mm distance to
agreement. The plan was accepted only if more than 95%
pixels having the value of γ ≤1 and rejected when γ ˃1.
Results
The DVH evaluation results of PTV and OARs are tabulated
in Table 1. There is no clinically significant difference in the
PTV Dmax and Dmean with respect to the different colli-
mator angles. The average of CI and HI values for PTV with
respect to the collimator angles 0 to 90 degree is listed in
Table 2. The PTV coverage is best at collimator angle of 0
degree. A slight reduction in CI was observed with plans at
other collimator angles as compared to 0 degree. However,
the difference is not clinically significant. Therefore, colli-
mator rotation does not compromise the PTV coverage. The
HI values were almost similar for plans with collimator angle
0, 30, and 60 degree. The plan with 90 degree collimator
showed a slightly higher heterogeneity for the PTV. How-
ever, there is no clinically significant difference between the
plans with respect to HI. The dose volume comparison curve
of PTV for a representative patient is shown in Figure 2(a).
A slight reduction in the average Dmax to spinal cord was
observed for the plan with collimator angle 30 degree as
compared to other angles. An increase in Dmax to spinal cord
was observed for collimator angle 60 degree as compared to 0
degree. No clinically significant difference was observed
among the plans with respect to brainstem and mandible
Dmax. A slight reduction in brainstem average Dmean was
seen at collimator angle 60 degree. The dose volume com-
parison curve of brainstem and spinal cord for a representa-
tive patient is shown in Figure 2(b).
An increase in average of oral cavity Dmax and Dmean was
observed for collimator angle 60 and 90 degree as compared
to collimator angle 0 and 30 degree (Table 1). However, this
difference is not clinically significant. The dose volume
comparison curve of oral cavity and mandible for a repre-
sentative patient is shown in Figure 2(c).
Not much difference was observed with respect to Dmax and
Dmean for contralateral parotid and cochlea with plans at
different collimator angles (Table 1). As these structures were
not directly shielded by the collimator, similar doses resulted
with plans at different collimator angles. The dose volume
comparison curve of contralateral parotid and cochlea for a
representative patient is shown in Figure 2(d).
The average of 2D γ index and MU required to deliver a plan
with collimator angle 0 to 90 degree is shown in Table 3. A
decrease in MU required to deliver a fraction was observed
for the plan with collimator angle 30 degree as compared to
other angles. The plan with 90 degree collimator required
maximum MU.
The 2D γ index evaluation of planned and delivered fluence
showed almost similar results for plans with different colli-
mator angles. The 2D γ index analysis of IBA I’mRT MatriXX
ionization chamber array measured fluence with the TPS
calculated fluence of a representative patient for collimator
angle 0 to 90 degree is shown in Figure 3(a-d).
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TABLE 1: The mean and standard deviation of the dose values for the target and organs at risk with plans at different collimator angles.
Structure 00 300 600 900
PTV Dmax (Gy) 64.38±1.68 64.84±0.74 64.81±0.92 64.86±1.29
PTV Dmean (Gy) 62.42±0.33 62.25±0.33 62.22±0.59 62.09±0.53
Spinal cord Dmax (Gy) 33.33±5.98 32.59±6.37 34.24±6.13 33.36±6.73
Brainstem Dmax (Gy) 28.77±2.53 28.99±2.45 28.32±2.47 28.12±4.75
Contra. Parotid Dmax (Gy) 13.94±6.89 14.23±7.17 14.11±6.97 14.11±7.29
Contra. Parotid Dmean (Gy) 6.52±2.19 6.55±1.93 6.71±1.86 6.80±1.82
Contra. Cochlea Dmax (Gy) 5.94±4.09 6.32±4.45 6.74±4.61 6.30±4.72
Contra. Cochlea Dmean(Gy) 4.15±3.59 4.63±4.30 5.02±4.02 4.59±4.10
Oral cavity Dmax (Gy) 50.02±10.58 50.68±10.96 51.70±9.18 58.73±7.02
Oral cavity Dmean (Gy) 20.13±5.71 20.80±6.32 21.32±6.78 21.18±6.71
Mandible Dmax (Gy) 63.99±0.57 63.94±0.60 63.98±0.89 63.71±0.62
Abbreviations: PTV = planning target volume; max = maximum; contra = contralateral
TABLE 2: The mean and standard deviation of the CI and HI values for the plans with respective collimator angles
Index 00 300 600 900
CI 0.9140±0.004 0.8938±0.057 0.8967±0.045 0.8895±0.046
HI 1.0793±0.008 1.0797±0.012 1.0787±0.012 1.0805±0.013
Abbreviations: CI = conformity index; HI = heterogeneity index
TABLE 3: The mean and standard deviation of the values of 2D γ index and MUs required to deliver a plan at the respective collimator angles
00 300 600 900
γ index 98.8±1.1% 98.8±1.6% 99.1±0.7% 99.1±0.8%
Total MUs 397±30 384±43 399±48 428±49
Abbreviations: MU = monitor units
FIG. 2(a-d): Plan comparison DVH of PTV and OAR’s for a representative patient at collimator angle from 0 to 90 degree.
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FIG. 3(a-d): The comparison of TPS calculated and I’matriXX measured 2D fluence gamma evaluation (3%/3 mm) result for a representative
patient at collimator angle of (a) 0 degree, (b) 30 degree, (c) 60 degree, and (d) 90 degree.
Discussion
The present study demonstrates that in terms of PTV cover-
age and plan homogeneity all collimator angles are compara-
ble in IMRT planning for parotid cancer. The reduction in
Dmax to spinal cord at the plan with collimator angle 30
degree illustrates that collimator rotation aids in delivering a
conformal dose without increasing the dose to OARs. More-
over, proper selection of collimator angle according to the
shape and curve of target and OARs is essential. A collimator
angle may be superior for target coverage but may not be
suitable for adjacent OARs. Therefore, while planning IMRT,
collimator angle should be selected according to the beam’s
eye view for the particular gantry angle.
While delivering dynamic IMRT, the MLC leaves move un-
der the jaws. At a specific collimator angle, the length of MLC
moving under the jaws may be maximum which aids in re-
ducing the inter- and intra-leaf transmission. This results in
achieving a better dose distribution.13, 14 In terms of delivera-
bility of modulated fluence with collimator rotation from 0 to
90 degree, no limitation was seen on the linear accelerator in
the current study. Furthermore, a reduction in MU was ob-
served at the plan with collimator angle 30 degree as com-
pared to other angles.
Chapek et al.14 elaborated on the addition of collimator pa-
rameter optimization i.e., both collimator angle and primary
jaw settings to IMRT in prostate cancer. This resulted in a
greater sparing of rectum as compared to intensity modula-
tion alone. However, the IMRT plan delivery with collimator
rotation becomes complex. The potential dosimetric ad-
vantages of incorporating MLC rotation in IMRT were also
investigated by Otto et al.15 The results showed that higher
spatial resolution dose distributions were attainable with the
rotational technique, which resulted in superior target cov-
erage and normal tissue sparing. It was also shown that in-
ter-leaf leakage and tongue-and-groove effects were substan-
tially reduced, decreasing the degree of systematic
over-dosing and under-dosing observed in conventional
IMRT delivery.
A study16 highlighted the dosimetric issues which must be
assessed before dynamic therapy with MLC can be imple-
mented. The authors performed a series of calculations and
measurements to quantify head scatter for small fields, col-
limator transmission, and the transmission through rounded
leaf ends. These factors affected the delivered dose to the
prostate by 5% to 20% for a typical plan. Thus, strict pa-
tient-specific pre-treatment plan quality verification and
perfect dosimetric modeling of MLC is crucial after rotating
the collimator.
Conclusion
A variation in maximum dose to spinal cord was observed at
IMRT plan with collimator angle 60 degree for parotid can-
cer. No clinically relevant difference was seen with respect to
the dose to remaining critical structures, PTV coverage, and
dose delivery by rotating the collimator from 0 to 90 degree.
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An individual case-specific collimator rotation may aid in
achieving the desired dose distribution and relative sparing of
critical structures in IMRT.
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